StreetAlpha
13F holdings · Q2 2026

Progeny 3

Kirkland, WA · files as Progeny 3, Inc.
Holdings as of Jun 30, 2026Filed Aug 14, 2026Next filing due Nov 16, 2026CIK 1536006

Progeny 3 reported 29 stocks worth $1.9B in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are CCJ (12.4%), IBKR (9.9%) and APG (7.7%). Compared with Q1 2026, the fund opened new positions in AROC and ASND, added to CCJ, TIC and SSNC, trimmed PAR and NRP and sold out of GFL, ABVX and PCVX.

Reported value$1.9B+3.6% vs last quarter
Stocks held292 new · 5 sold out
Top 5 weight41.9%fairly concentrated
Turnover10%of the portfolio changed
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
CCJ
Cameco Corp F
$241M12.4%2.4M+20K (+1%)8 of 8
2
IBKR
Interactive Brokers Grouclass Class A
$191M9.9%2.2MNo change8 of 8
3
APG
Api Group
$150M7.7%3.5MNo change8 of 8
4
TIC
Acuren Corp
$126M6.5%15.6M+240K (+2%)6 of 8
5
IVV
Ishares TR
$104M5.4%139KNo change8 of 8
6
SSNC
Ss&C Technologies Hldgs Inc
$82.7M4.3%1.3M+74K (+6%)8 of 8
7
ARLP
Alliance Resource Partners L
$77.9M4.0%3.2M+19K (+1%)8 of 8
8
VOO
Vanguard S&P 500 ETF
$70.9M3.7%103KNo change8 of 8
9
MLM
Martin Marietta Matls Inc
$65.3M3.4%113KNo change6 of 8
10
SOLS
Solstice Advanced Matls Inc
$64.8M3.3%731KNo change3 of 8
🔒 19 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q1 2026, gone in Q2 2026
StockValue last quarterShares sold
GFL
Gfl Environmental
$80.8M1.9M
ABVX
Abivax SA
$1.4M12K
PCVX
Vaxcyte Inc
$1.4M23K
ASND
Ascendis Pharma A/s
$1.2M5,230
CRINETICS PHARMACEUTICALS IN
$872K24K

Reported value

last 8 quarters
$1.2BQ3 '24
$1.3BQ4 '24
$1.5BQ1 '25
$1.8BQ2 '25
$1.9BQ3 '25
$1.9BQ4 '25
$1.9BQ1 '26
$1.9BQ2 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q2 2026

straight from the SEC
FiledFormQuarter
Aug 14, 202613F-HRQ2 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Progeny 3 13F FAQ

What does Progeny 3 own?

Progeny 3 reported 29 stocks worth $1.9B in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are CCJ (12.4%), IBKR (9.9%) and APG (7.7%). The table above lists every position in the filing (the top 10 without an account).

What did Progeny 3 buy and sell in Q2 2026?

Compared with Q1 2026: 2 new positions, 8 added to, 2 trimmed and 5 sold out. New positions include AROC and ASND. It sold all of GFL, ABVX and PCVX.

When will Progeny 3 file its next 13F?

Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.

How much is Progeny 3's portfolio worth?

The Q2 2026 filing reports $1.9B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.